AUGUST 30, 2022

Nonalcoholic Steatohepatitis: Identifying High-Risk Patients

Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF

Professor of Medicine
Department of Medicine
University of South Dakota
Sanford School of Medicine
Transplant Hepatologist
Avera McKennan University Hospital
Chief, Clinical Research
Avera Transplant Institute
Sioux Falls, South Dakota

 

Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat deposition in the liver in the absence of other causes of liver disease, including harmful consumption of alcohol.1 The disease spectrum ranges